Highlights
NASDAQ: ARNA       Arena Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
44.51   -1.30 (2.84%)  44.25 - 46.34  533,500

Overview

 
Avg Volume (4 weeks):456,850
4 Weeks Range:43.40 - 47.70
4 Weeks Price Volatility (%):
25.81%
52 Weeks Range:42.48 - 64.48
52 Weeks Price Volatility (%):
9.23%
Average Price Target: 6.00
Price Target Upside/Downside: -38.51

Headlines



No recent Headlines for this stock.


Business Background

Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company’s pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

  Be the first to like this.
 


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers